Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (231-240 of 574) with videos related to

Pageof 58
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 13, 2023
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 TrialJames Chih-Hsin Yang, Geoffrey Liu, Shun Lu, et al.
Clinical Lung Cancer|February 25, 2019
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care SystemDoreen A Ezeife, Brandon Josh Morganstein, Sally Lau, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|November 4, 2021
Association of gastro-oesophageal reflux disease and quality of life in patients with chronic rhinosinusitisYang Xu, Wen Yang, Yao Song, et al.
Journal of the National Cancer Institute|January 9, 2026
Targeting common EGFR mutations in NSCLC-review of global phase III trials of third-generation inhibitorsBarbara Melosky, Rosalyn A Juergens, Quincy S C Chu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk CohortsReenika Aggarwal, Andrew C L Lam, Maureen McGregor, et al.
The Oncologist|August 15, 2019
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre ExperienceHamzeh Albaba, Tristan A Barnes, Zachary Veitch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Patient-Derived Xenograft Establishment from Human Malignant Pleural MesotheliomaLicun Wu, Ghassan Allo, Thomas John, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 30, 2017
Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell CarcinomaAndrew Foreman, Daniel J Lee, Caitlin McMullen, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial IntelligenceRuth Moulson, Jennifer Law, Adrian Sacher, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2021
Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapySally C M Lau, Christopher Poletes, Lisa W Le, et al.
Pageof 58

Showing results (231-240 of 574) with videos related to

Sort By:
Pageof 58
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 13, 2023
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 TrialJames Chih-Hsin Yang, Geoffrey Liu, Shun Lu, et al.
Clinical Lung Cancer|February 25, 2019
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care SystemDoreen A Ezeife, Brandon Josh Morganstein, Sally Lau, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|November 4, 2021
Association of gastro-oesophageal reflux disease and quality of life in patients with chronic rhinosinusitisYang Xu, Wen Yang, Yao Song, et al.
Journal of the National Cancer Institute|January 9, 2026
Targeting common EGFR mutations in NSCLC-review of global phase III trials of third-generation inhibitorsBarbara Melosky, Rosalyn A Juergens, Quincy S C Chu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk CohortsReenika Aggarwal, Andrew C L Lam, Maureen McGregor, et al.
The Oncologist|August 15, 2019
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre ExperienceHamzeh Albaba, Tristan A Barnes, Zachary Veitch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Patient-Derived Xenograft Establishment from Human Malignant Pleural MesotheliomaLicun Wu, Ghassan Allo, Thomas John, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 30, 2017
Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell CarcinomaAndrew Foreman, Daniel J Lee, Caitlin McMullen, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial IntelligenceRuth Moulson, Jennifer Law, Adrian Sacher, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2021
Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapySally C M Lau, Christopher Poletes, Lisa W Le, et al.
Pageof 58